Calvin University

Calvin Digital Commons
University Faculty Publications

University Faculty Scholarship

11-1-2016

Fetal brain lesions after subcutaneous inoculation of Zika virus in
a pregnant nonhuman primate
Kristina M. Adams Waldorf
University of Washington

Jennifer E. Stencel-Baerenwald
University of Washington

Raj P. Kapur
University of Washington

Colin Studholme
University of Washington

Erica Boldenow
Calvin University

Follow this and additional works at: https://digitalcommons.calvin.edu/calvin_facultypubs
Part of the Epidemiology Commons

Recommended Citation
Adams Waldorf, Kristina M.; Stencel-Baerenwald, Jennifer E.; Kapur, Raj P.; Studholme, Colin; and
Boldenow, Erica, "Fetal brain lesions after subcutaneous inoculation of Zika virus in a pregnant nonhuman
primate" (2016). University Faculty Publications. 193.
https://digitalcommons.calvin.edu/calvin_facultypubs/193

This Article is brought to you for free and open access by the University Faculty Scholarship at Calvin Digital
Commons. It has been accepted for inclusion in University Faculty Publications by an authorized administrator of
Calvin Digital Commons. For more information, please contact dbm9@calvin.edu.

b r i e f c o m m u n i c at i o n s

© 2016 Nature America, Inc., part of Springer Nature. All rights reserved.

Fetal brain lesions after sub
cutaneous inoculation of Zika
virus in a pregnant nonhuman
primate
Kristina M Adams Waldorf1, Jennifer E Stencel-Baerenwald2,3,21,
Raj P Kapur4,5,21, Colin Studholme6–8,21, Erica Boldenow6,9,20,21,
Jay Vornhagen9,10,21, Audrey Baldessari11, Manjiri K Dighe8,
Jeff Thiel8, Sean Merillat9, Blair Armistead9,10, Jennifer Tisoncik-Go2,3,
Richard R Green2,3, Michael A Davis2,3, Elyse C Dewey2,3,
Marian R Fairgrieve2,3, J Christopher Gatenby8, Todd Richards8,
Gwenn A Garden4,12, Michael S Diamond13–16, Sandra E Juul6,
Richard F Grant11, LaRene Kuller11, Dennis W W Shaw8,17,
Jason Ogle11, G Michael Gough11, Wonsok Lee11, Chris English11,
Robert F Hevner18,19, William B Dobyns6,19, Michael Gale Jr2,3
& Lakshmi Rajagopal6,9,10
We describe the development of fetal brain lesions after Zika virus
(ZIKV) inoculation in a pregnant pigtail macaque. Periventricular
lesions developed within 10 d and evolved asymmetrically in the
occipital–parietal lobes. Fetal autopsy revealed ZIKV in the brain
and significant cerebral white matter hypoplasia, periventricular
white matter gliosis, and axonal and ependymal injury. Our
observation of ZIKV-associated fetal brain lesions in a nonhuman
primate provides a model for therapeutic evaluation.
The recent ZIKV epidemic in the Americas has been declared a global
public health emergency because of its association with severe fetal
brain injury during infection of pregnant women. ZIKV is a mosquitotransmitted flavivirus that generally causes a self-limited febrile syndrome characterized by rash, conjunctivitis and arthralgia. However,
infection in pregnant women is a major concern because the fetus
may develop a range of brain anomalies, including cerebral atrophy,
ventriculomegaly, cerebellar hypoplasia and ocular manifestations1.
Although ZIKV infection can induce fetal demise in mice2–4, the
lack of an experimental animal model of ZIKV infection that closely
emulates human pregnancy has hindered the ability to directly test

the causal relationship between ZIKV infection and fetal brain injury5.
Here we describe the development of a pregnant pigtail macaque
model of ZIKV infection that results in fetal brain lesions. Our results
confirm the teratogenic potential of ZIKV and will enable testing of
therapeutics to prevent fetal brain injury.
We inoculated ZIKV (strain FSS13025, Cambodia 2010) subcutaneously in five locations on the forearms of a pregnant pigtail
macaque at 119 d gestation (corresponding to ~28 weeks of human
pregnancy) to test whether ZIKV causes fetal brain injury. Each of
the five inoculations consisted of 107 plaque-forming units (p.f.u.) of
ZIKV. The pregnant animal appeared healthy and did not develop signs
of rash, conjunctivitis or fever. Cesarean section was performed before
the onset of labor at 162 d gestation (corresponding to ~38 weeks
of human pregnancy). A weekly ultrasound demonstrated a lag in
the growth of the fetal biparietal diameter (BPD) (Fig. 1a) that ultimately fell three standard deviations as compared to the published
ultrasound data for fetal pigtail macaques6. In contrast, the femur continued to grow normally (Fig. 1b). Baseline imaging of the fetal head
showed normal architecture of the cerebral hemispheres, ventricles
and posterior fossa; over time, a heterogeneous linear echogenic area
developed adjacent to the lateral ventricle in the posterior brain of the
ZIKV-infected animal (Fig. 1c) that was not seen in a control fetus at
a similar stage of gestation (Fig. 1d).
The first magnetic resonance imaging (MR imaging, or MRI) of the
fetal brain was performed 10 d following ZIKV inoculation and demonstrated bilateral periventricular T2 hyperintense foci in the occipital–
parietal regions surrounding the occipital horns of the lateral ventricles (Fig. 1e and Supplementary Figs. 1–3). This abnormality evolved
over the course of the study and enlarged on the right; on the left,
the T2 hyperintense focus became hypointense and was associated
with volume loss and ventricular collapse. White matter volume did
not change significantly over the last 3 weeks of the study (17–43 d
after inoculation), which correlated with the plateau in growth of the
biparietal diameter on the ultrasound image; in contrast, the gray matter consistently increased in volume (Fig. 1a, Supplementary Fig. 4
and Supplementary Table 1). The white matter surface area, shape
and cortical folding continued to evolve (Supplementary Figs. 4 and 5
and Supplementary Table 1). Normally, during the latter half of
pregnancy in the macaque, the posterior ventricular cerebrospinal
fluid regions reduce in size relative to the more rapid development
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Figure 1 Fetal biometry, ultrasound and serial fetal brain MR imaging of a ZIKV-infected pregnant pigtail macaque. (a,b) Fetal biparietal diameter
(BPD) (a) and femur length (b) of a ZIKV-infected pregnant pigtail macaque over time, as measured by ultrasound and compared to published
reference data for fetal growth; each individual line refers to the mean and standard deviation (s.d.) extrapolated from the tables in the reference
for the pigtail macaque6. (c) An axial image of the fetal head obtained by ultrasound at 161 d gestation from the ZIKV-infected fetus. The large
white arrow indicates a heterogeneous linear echogenic area in the posterior cerebral cortex on the right side. Other visible structures include the thalamus
(Th) and falx (small white arrows). Labels indicate the anterior (A) and posterior (P) orientation. (d) An analogous image to c is shown for a control
fetus at 163 d gestation. In c,d, scale bars, 1 cm. (e) Serial axial (top), sagittal (middle) and coronal (bottom) MR images of the fetal brain in a ZIKVinfected pregnant pigtail macaque from 10 to 43 d after inoculation (129–162 d gestation). The red arrowheads indicate T2 hyperintense foci in the
bilateral periventricular regions of the occipital–parietal brain. Numbers shown at the top of the image indicate ‘time after inoculation (d)/time
of gestation (d)’. Scale bar, 40 mm (top).

of the parietal and occipital lobes. In contrast, after ZIKV inoculation large posterior ventricular cerebrospinal fluid spaces persisted
into late gestation. The surrounding posterior white matter also
showed enhancement in T2 weighting, indicating increased water
content (Supplementary Table 1). There was no evidence of cortical
malformation or abnormalities of the brainstem or cerebellum by
MR imaging. MR spectroscopy demonstrated a marked reduction
in N-acetyl aspartate (NAA), a metabolite associated with neuronal
integrity, in the posterior versus the anterior brain (Supplementary
Fig. 6). The rapid development of an enhancing T2-weighted fluid
abnormality suggests that fetal brain injury begins to occur quickly
following ZIKV infection and may induce periventricular white
matter injury similar to that seen after infection with other viruses
that cause neonatal encephalitis7,8.
Macroscopic examination of the ZIKV-infected fetal brain revealed
marked deficiency of the posterior white matter as compared to the
control fetal brain (Fig. 2a,b). White matter gliosis was present bilaterally with many apoptotic and mitotic figures in contrast to the
control fetus (Fig. 2c–f). Immunohistochemistry revealed increased
density of glial fibrillary acidic protein (GFAP)-positive reactive
astrocytes, predominantly in the white matter, as compared to the
control fetus (Fig. 2g,h), and increased CD163-positive microglial
cells (data not shown). Flow cytometry analysis of matched regions
of the fetal and maternal brain indicated an enrichment of astrocytes in the fetal brain (Supplementary Table 2). Ovoid eosinophilic
structures were seen in the gliotic white matter that were consistent with axonal spheroids (Fig. 2f, inset), a pathologic sign of axon
injury. The occipital horn of the right lateral ventricle was mildly
dilated. There was mild focal gliosis in the gray matter. Notably, there
was bilateral patchy loss of ventricular ependymal epithelium with
underlying parenchymal hypercellularity (Supplementary Fig. 7b)
and increased activated caspase-3 immunoreactivity (Supplementary
Fig. 7d); CD163-positive histiocytes adhered to the denuded ventricle
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surface (data not shown). In contrast, few caspase-3-immunoreactive
cells were present in the periventricular zone of an uninfected
fetal control (Supplementary Fig. 7c). Minimal inflammation
was observed in the brain parenchyma and meninges; CD20- and
CD3-positive cells were rare (not shown). Necrosis, hemorrhage or
calcifications were absent. Other maternal and fetal organs, including
the fetal brainstem, did not show pathological signs of injury. Placental
histopathology revealed only mild deciduitis, which was also present
in some uninfected controls.
Prior to inoculation, serology was negative for previous infection
with ZIKV, dengue virus (DENV), West Nile virus (WNV) or chikungunya virus (CHIKV) (data not shown). The dam became seropositive
for ZIKV-specific IgG at 14 d after inoculation and remained positive;
the fetus was seropositive at birth (Supplementary Table 3). At delivery,
ZIKV RNA was detected in the chorionic villous tissue of the placenta,
the fetal brain and liver, and the maternal brain, eyes, spleen and
liver (Fig. 2i and Supplementary Table 4). Whole-transcriptome
sequencing analysis of brain tissues identified ZIKV RNA in both
fetus (1,298 reads per mg tissue) and dam (340 reads per mg tissue),
with sequence-read coverage across the complete ZIKV genome,
including the nontranslated regions (Fig. 2j). No viral sequences were
identified in the brain of an uninfected female pigtail macaque. Viral
plaque assays on all tissues with detectable ZIKV RNA were negative
for replicating virus, indicating that either the infection had resolved
or the level of infectious virus was too low for recovery using standard
plaque assay methodology.
Our findings of arrested fetal brain growth and viral neuro-invasion
are consistent with the congenital ZIKV syndrome seen in humans.
The marked lag in fetal BPD growth by ultrasound analysis reflects the
arrest of white matter expansion detected by MR imaging. A similar
arrest in BPD has been reported in human pregnancy with presumed
ZIKV infection in the third trimester9. In the context of ZIKV infection, this change in fetal brain growth would be very concerning for
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Figure 2 Neuropathology of the ZIKV-infected fetal brain and ZIKV RNA in fetal and dam tissues. (a–f) Representative H&E-stained images of the
brains from one ZIKV-infected fetus (b,d,f) and a control fetus (a,c,e) are shown. White asterisks (b) indicate pink bands of white matter hypoplasia
and gliosis. Neurofilament staining (f, inset) indicates an axonal spheroid, which were only seen in the ZIKV-infected fetus. Scale bars, 1 mm (a,b),
500 µm (c,d), 100 µm (e,f) and 50 µm (f, inset). (g,h) Representative image from the entire brain section showing GFAP immunostaining in the
control (g) or ZIKV-infected fetus (h). (i) ZIKV RNA levels in dam and fetal tissues, as measured by a virus-specific qRT–PCR assay. Data are mean ±
s.d. (j) Schematic of the ZIKV FSS13025 genome (top) and viral sequence reads across the ZIKV FSS13025 genome (GenBank accession number
KU955593), as determined by RNA-seq analysis in brain tissues from the ZIKV-infected fetus and dam. The data were compared to that of the mock
control, which was the total RNA-seq data from the temporal lobe of a female, uninfected pigtail macaque (Macaca nemestrina) that was obtained
through the Nonhuman Primate Reference Transcriptome Resource (http://www.nhprtr.org).

impending microcephaly if given sufficient time, but our experimental duration was relatively short (a single pregnancy trimester). Viral
neuro-invasion was supported by detection of ZIKV RNA in the fetal
and maternal brain, histopathology and fetal serology. The highest
copy number of ZIKV RNA was found in placental chorionic villous
tissue, which may be the source of the prolonged viremia that has
been described in both pregnant humans and rhesus macaques 10,11.
In summary, clinical findings and evidence for viral neuro-invasion is
highly consistent with vertical transmission, congenital ZIKV infection and fetal brain injury in our model.
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In contrast to our findings, a prior study of ZIKV infection in pregnant rhesus macaques did not observe changes in fetal brain growth;
ZIKV RNA was detected in only a few fetal organs (lymph node,
bone marrow and optic nerve) in one of three experiments (https://
zika.labkey.com/project/home/begin.view?; last accessed August 1,
2016)11. Discrepancies may be due to differences in the nonhuman
primate species used and the inoculum dose. We chose an inoculum
dose based on a study assessing viral load of WNV; during a mosquito
bite, inoculated virus ranges from 102–107 infectious viral particles12.
Mosquitoes typically deposit virus several times as they ‘probe’
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before they ‘bite’. A prior study also indicated a viral load of up to 108
tissue culture infectious dose 50 (TCID50) in the salivary gland of
the Aedes aegypti mosquito13. Thus, we chose a viral dose at the higher
end of the spectrum to mimic the multiple probes and bite of an
infected, feeding mosquito.
We describe the first case of fetal brain injury in a nonhuman
primate after maternal infection with ZIKV. Arrested fetal brain
growth, white matter injury and detection of ZIKV RNA in multiple
fetal organs (brain, liver and placenta) are similar to features of
the congenital ZIKV syndrome in humans. The distribution of white
matter injury in this case is predicted to result in visual-field loss
(injury to optic tracts) and neurodevelopmental delay 14. A similar
but more severe pattern of white matter injury, with involvement of
the occipital horns of the lateral ventricle, was also seen in a Brazilian
child with congenital ZIKV infection (Supplementary Fig. 8). We did
not observe many of the severe findings associated with the congenital
ZIKV syndrome, but we speculate that this may be due to terminating the study 6 weeks after inoculation because the pregnancy was
nearing the due date.
Nonhuman primates are ideal for studying infection in pregnancy because they most closely mimic human gestation in many
key respects, including placentation, gray/white matter ratios in
the brain and timing of neurodevelopment15. The pigtail macaque
is known to be susceptible to multiple Flaviviridae family members
(such as DENV, Japanese encephalitis virus and hepatitis C virus),
which makes them an excellent model for ZIKV infection16–19. In
summary, we demonstrate that a clinically inapparent maternal ZIKV
infection during pregnancy has the capacity to result in fetal brain
injury in a pregnant pigtail macaque. Further studies are needed to
investigate the mechanisms of fetal injury. The pigtail macaque model
may have significant utility for testing novel vaccines and therapeutics
to prevent the congenital ZIKV syndrome.
Methods
Methods and any associated references are available in the online
version of the paper.
Accession codes. Gene Expression Omnibus: all sequencing data are
available under accession code GSE84614.
Note: Any Supplementary Information and Source Data files are available in the
online version of the paper.
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Primate experiments. The nonhuman primate experiments were carried
out in strict accordance with the recommendations in the Guide for the
Care and Use of Laboratory Animals20 of the National Research Council and
the Weatherall report21. The Institutional Animal Care Use Committee of the
University of Washington approved the study (permit number: 4165-02).
We inoculated ZIKV (strain FSS13025, Cambodia 2010) subcutaneously in
five separate locations on the forearms, each with 107 plaque-forming units
(p.f.u.) into a healthy pregnant, 9-year-old pigtail macaque (M. nemestrina) at
119 d gestation (~28 weeks of human pregnancy) to test directly whether ZIKV
causes fetal brain injury. At the time of cesarean section and fetal necropsy,
the fetus was at 162 d gestation (term pregnancy = 172 d).
Definition of fever in the pigtail macaque. The definition of a fever in a pigtail
macaque is not standardized. A range of rectal temperatures (from 36.6 to 40.1 °C;
average 38.8 °C)22 has been reported in sedated rhesus and cynomolgus
macaques (M. mulatta and M. fascicularis), which are close relatives to the pigtail
macaque. Individual variation is thought to relate to excitement before sedation
and lowering of body temperature during sedation. The highest maternal rectal
temperature recorded in the study was 38.2 °C (100.8 °F), which was not thought
to represent a fever.
Ultrasound. Fetal dates were determined initially by measurement of the
crown rump at 45 d; ultrasound measurements of the biparietal diameter (BPD) at 101 d gestation supported the dating. Thereafter, ultrasound
was performed every week from inoculation until delivery. A GE Vivid-i
(GE Medical, Waukesha, WI, USA) machine was used for the first ultrasound,
and all subsequent measurements were performed on the Philips HD11 machine
(Philips Healthcare, Bothell, WA, USA). A curvilinear C5-2 MHz transducer
was used to image the fetus. At least three measurements of the head circumference, abdominal circumference, BPD and femur length were acquired, and the
average was calculated. In addition, at least three ventricular measurements in
the dependent ventricle, transverse cerebellar diameter and placental thickness
were acquired, and an average measurement was calculated. At least two cine
clips were acquired through the head in an axial and coronal orientation, and
through the chest and abdomen in an axial orientation. Doppler ultrasound of
the middle cerebral artery was performed to evaluate the flow through the brain.
Amniotic fluid index was calculated by measuring the fluid pockets in the four
quadrants. Fetal biometry was compared to known standards for the pigtail
macaque6. Ultrasound was also performed on a control fetus at 163 d gestation.
A board-certified radiologist (M.K.D.) with 13 years of experience in obstetric
ultrasound reviewed the imaging.
Magnetic resonance imaging. MR imaging was performed using a Philips
Achieva 3T scanner and a multi-element human cardiac radiofrequency (RF)
coil. Anesthesia was induced using 5–20 mg per kg body weight ketamine and
maintained using no higher than a 3% sevoflurane–oxygen mixture during the
imaging. A three-plane localizer using a balanced fast-field echo (FFE) imaging
sequence was used to determine fetal head position. A two-dimensional (2D)
single-shot, half-Fourier turbo spin echo multislice sequence was used to acquire
T2-weighted images with the following parameters: TR/TE = 2,200/160 ms,
SENSE acceleration factor = 2, TSE factor = 100, along with fat suppression and
fold-over artifact suppression. Multiple contiguous 2D image stacks, with in-plane
resolutions of 0.5 × 0.5 mm and thicknesses of 2 mm, were acquired along the
fetal brain axial, sagittal and coronal axes to facilitate the reconstruction of a
3D volume with isotropic spatial resolution. Each 2-mm-thick plane orientation was repeated six times to provide high signal-to-noise ratio in the final
combined 3D reconstruction. Diffusion MR imaging data were also acquired
but not analyzed in this case report. A pediatric neuroradiologist (D.W.W.S.) and
a pediatric geneticist with expertise in human developmental brain disorders
(W.B.D.) qualitatively reviewed the MRI images.
To form a single high-resolution 3D T2W image volume for quantitative analysis
of tissue brain volume and surface anatomy, all multislice T2-weighted image stacks
were imported into the SLIMMER slice motion correction tool23 implemented
in the rview software (http://rview.colin-studholme.net, version 9.077.155BQT
running under Ubuntu release 14) for initial volume-based alignment
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to correct for gross drift of the fetal head between slice stacks and to define
a standardized orientation of the fetal head anatomy. Between-slice motion
occurring due to maternal breathing and fetal head drift was then estimated
using slice intersection motion correction24. Differences in signal intensity arising from drift of the fetal head with respect to the imaging coils during scanning
and from intensity variations due to spin history arising from motion between
excitation and readout of each individual slice were corrected using slice-intersection-bias correction. Then, all slices were combined using an iterative deconvolution-based super-resolution 3D-scattered data reconstruction technique,
using robust Huber-norm outlier rejection of any residual within-slice motion
artifacts25. The final de-convolved isotropic spatial sampling resolution of this
image was selected to match the in-plane resolution of each slice (0.5 mm).
Each reconstructed 3D brain image volume was first masked to exclude skull
and maternal tissues. As no age-specific atlas is available for this species, the
MR imaging scan was roughly segmented into gray matter, white matter and
cerebrospinal fluid (CSF) using an initial K-means clustering initiated from a
manually selected set of voxels in each tissue class. The output of this was then
extensively manually edited using the review segmentation tool (http://rview.
colin-studholme.net, version 9.077.155BQT running under Ubuntu release 14)
to divide the tissues further into cortical and deep gray matter, white matter,
cerebellum, sulcal cerebrospinal fluid and ventricular cerebrospinal fluid.
In addition, regions of age-abnormal fluid representing abnormal posterior
ventricular CSF regions and any surrounding unconnected regions of high
T2W signal were separately labeled as abnormal fluid volume. From these we
calculated the total supratentorial cortical gray matter, white matter and deep
gray matter, the total cerebellum volume and the abnormal fluid volume in
cubic centimeters. The boundary between the gray and white matter voxels
was converted to a topologically correct triangular surface mesh with an initial
voxel-label topology correction using an implementation of Bazin et al.26 and
then tessellated using an implementation of the marching cubes algorithm. This
inclusive whole-brain surface includes the regions of the hemispheric connections and the truncation surface at the brain stem. The area of all triangles in the
surface was then summed to create a single surface area estimate for the brain
at each time point in square centimeters.
MR spectroscopy (MRS). Single-voxel MRS was acquired using a point-resolved
spectroscopy pulse sequence (voxel size: 15 × 12.5 × 15 mm) centered on a frontal region and a posterior region. The structural image was reconstructed in real
time to guide MRS voxel placement. Acquisition parameters included: repetition
time TR = 2,000 ms; echo time TE = 32 ms; 2,048 complex free-induction decay
points, and 2,000-Hz spectral width. Absolute concentrations of metabolites:
N-acetyl aspartate (NAA), creatine (Cr), choline (Cho), myoinositol (Ins), glutamate (Glu) and glutamate + glutamine (Glx) were calculated using LCModel27.
Absolute concentrations were obtained by scaling the in vivo spectrum to the
unsuppressed water peak and are reported in units that approximate millimolar
concentrations. Partial volume corrections were made by calculating the fraction
of cerebrospinal fluid for each voxel.
Cultures. Bacterial cultures were performed to exclude microbial infection.
Amniotic fluid, and maternal and fetal blood, were collected at necropsy and
plated on tryptic soy agar (TSA) plates and incubated up to 48 h at 37 °C in 5% CO2.
Maternal and fetal meninges and membranes were swabbed and streaked on
TSA plates and incubated up to 48 h at 37 °C in 5% CO2. No bacteria were
cultured from any these samples.
Serology for WNV, CHIKV, DENV and ZIKV. We used virus-specific ELISA
assays for ZIKV-, WNV-, CHIKV- or DENV-specific IgG to test ultravioletinactivated plasma according to the manufacturer’s (Express Biosystems,
Frederick, MD) instructions. Diluted plasma samples were added to the wells of
the ELISA plate, which was coated with viral antigens, and incubated at 37 °C for
45 min. Wells were washed five times, and peroxidase conjugate was added to each
well and incubated for 45 min at 37 °C. Following incubation, the plate was washed
five times, followed by the addition of 2,2′-azino-bis(3-ethylbenzothiazoline6-sulfonic acid)-peroxidase substrate to each well. The plate was incubated at
room temperature for 30 min, and the absorbance of the colorimetric reaction
in each well was read within 15 min on a plate reader at 405 nm.
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Immunohistochemistry. The Seattle Children’s Hospital Pathology Department
performed the immunohistochemistry for GFAP, cleaved caspase-3, CD3, CD20,
CD163 and neurofilament on formaldehyde-fixed paraffin-embedded sections
of cerebral cortex from the Zika-exposed fetus and an age-matched control.
Immunostaining was performed with an automated immunostainer (Ventana,
Tucson, AZ) using the reagents and dilutions shown in Supplementary Table 5.
Appropriate peroxidase-conjugated secondary antibodies and diaminobenzidinebased reaction product were used to visualize sites of immunoreactivity.
Results were compared to two controls that were close in gestational age
(142 and 155 d gestation).
Cell lines and virus. Vero cells obtained from ATCC were cultured in Dulbecco’s
modified Eagle’s medium (DMEM; Cellgro) supplemented with 10% FBS
(FBS; Hyclone, Logan, UT), 2 mM l-glutamine, 1 mM sodium pyruvate, 100 U/mL
penicillin, 100 µg/mL streptomycin and 1× non-essential amino acids (Sigma).
Zika virus strain FSS13025 was isolated in Cambodia in 2010 and provided by
the World Reference Center of Emerging Viruses and Arboviruses (WRCEV,
Galveston, Texas, USA). Working stocks were obtained by plaque-purifying
virus and amplifying once in Vero cells. Virus was adsorbed to cells in DMEM
supplemented to contain 1% FBS at 37 °C for 2 h. The inoculum was removed,
and the virus was propagated in medium supplemented to contain 5% FBS, 2 mM
l-glutamine, 1 mM sodium pyruvate, 100 U/mL penicillin, 100 µg/mL streptomycin, 20 mM HEPES and 1× non-essential amino acids (Sigma). Supernatants
were collected and spun at 2,000 r.p.m. at 4 °C for 10 min and frozen in aliquots
at −80 °C. All of the cell lines used lacked mycoplasma.
Measurement of viral RNA load. Viral RNA load was assessed in tissues from
the dam, fetus and placenta using a ZIKV-specific RT–qPCR assay. Fetal and
maternal organs were placed in RNA-later (Qiagen, Valencia, CA) immediately
after harvest. For analysis of Zika virus RNA in tissue, organs were weighed
and homogenized in buffer RLT (Qiagen, Valencia, CA) using a bead-beater
apparatus (Precellys, Bertin Corp., Rockville, MD). RNA was extracted from
tissues using the RNeasy kit (Qiagen, Valencia, CA). Following RNA extraction,
cDNA was synthesized using the iScript select cDNA synthesis kit (Bio-Rad,
Hercules, CA) according to manufacturer’s protocols for gene-specific primers.
Viral RNA was quantified using the Taqman Universal Master Mix (Applied
Biosystems, Waltham, MA) and an Applied Biosystems 7300 RT–PCR machine
using primers previously described28. Primer sequences listed in Supplementary
Table 6 correspond to residues in the FSS13025 genome (GenBank accession
number KU955593). A standard curve was generated by serially diluting a plasmid containing residues 699–2,382 of the Zika virus genome. The standard curve
was used to extrapolate the number of copies of Zika virus RNA per mg of tissue.
To adhere to stringent guidelines, Ct (cycle threshold) values >38 were deemed
as not reliably detected and were not reported.
Plaque assay. Monolayers of Vero cells were plated in 6-well plates. Tissue
homogenates, CSF or viral stocks were serially diluted in DMEM supplemented
to contain 1% FBS. These dilutions were adsorbed to monolayers of Vero cells
at 37 °C for 2 h. The inoculum was replaced with a 1% agarose overlay, as previously described for West Nile Virus29. Five days following inoculation, a second
1% agarose overlay containing 2% neutral red (Sigma) was added to the cells.
Plaques were counted 4 h after the second overlay.
Library construction and transcriptome sequencing. Ribosomal RNA (rRNA)
was depleted from each RNA sample using the Ribo-Zero rRNA Removal Kit
(Epicentre, Madison, WI) following the manufacturer’s instructions. Libraries
were prepared from 150 ng of rRNA-depleted RNA following the KAPA
Stranded RNA-seq with RiboErase workflow for Total RNA-seq libraries (KAPA
Biosystems, Wilmington, MA). Library quality was evaluated using the Qubit
3.0 Fluorometer and the Agilent 2100 Bioanalyzer instrument. Constructed
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libraries were sequenced on a NextSeq 500 Illumina platform, producing
2 × 75 nucleotide stranded paired-end reads (52 Gb).
Data processing and viral read mapping. Quality control of the primary
sequencing data was performed using FastQC (version 0.11.3) and included
adaptor trimming using cutadapt (version 1.8.3). FastQC showed good quality
statistics across all samples. Ribosomal RNA reads were removed computationally using Bowtie2 with an index composed of human, mouse and rat
rRNA sequences. Sequence reads were trimmed to 50 bp and then aligned to
the reference FSS13025 genome (Genbank number: KU955593) using Bowtie2
with default settings. Viral read alignment was visualized using the Integrative
Genomics Viewer (IGV) tool30,31. Primary Total RNA-seq data from the temporal lobe of a female, uninfected pigtail macaque (M. nemestrina) was obtained
through the Nonhuman Primate Reference Transcriptome Resource (http://
www.nhprtr.org) to serve as a control32. All primary sequence data are available
at Sequence Read Archive (SRA) under the Gene Expression Omnibus (GEO)
accession GSE84614. Raw sequence data was uploaded to the GEO and SRA
databases (GSE84614).
Flow cytometry. Flow cytometry was performed on maternal and fetal brain tissues. To generate single-cell suspensions of brain tissue, each tissue was filtered
through a 280-µm metal sieve, pelleted at 500g for 5 min, washed once in sterile
PBS, resuspended in FACS buffer (1 mM EDTA, 25 mM HEPES and 0.1% BSA
(wt/vol) in PBS) and placed on ice until staining. Single-cell suspensions were
pelleted at 500g for 5 min and diluted to ~107 cells/mL in FACS buffer. Cell
suspensions (100 µL) were treated with Fc block (1:200; BD Biosciences) for
15 min at 4 °C. After Fc block treatment, cells were stained with anti-CD56
(1:10; clone B159) for 1 h at 4 °C (all antibodies are from BD Biosciences unless
noted otherwise). Cells were washed twice in FACS buffer to remove excess
antibody, fixed for 15 min at 4 °C with 2.0% paraformaldehyde, then permeabilized in 0.1% (vol/vol) Triton X-100 for 15 min at room temperature. Following
permeabilization, cells were washed once in FACS buffer to remove Triton X-100
and stained with anti-GFAP (1:10; clone REA335; Miltenyi Biotec) for 1 h at
4 °C. After intracellular staining, cells were washed twice in FACS buffer and
analyzed using an LSRII flow cytometer (BD Biosciences). Cell surface and
intracellular markers were analyzed using FlowJo software version 10.1 (FlowJo).
Unstained and single-color compensation beads (BD Biosciences) were included
for compensation.
Approval for de-identified human subjects. The Seattle Children’s Hospital
Institutional Review Board for Protection of Human Subjects approved the use
of de-identified MRI images.
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